Shionogi Announces Launch of Mulpleo® (lusutrombopag) in the UK, for the Treatment of Severe Thrombocytopenia in Adult Patients With Chronic Liver Disease Undergoing Invasive Procedures
Mulpleo (lusutrombopag) is the first licensed treatment now available through the National Health Service (NHS) in the UK to treat…